• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理解初级保健试验结果的适用性:应用PRECIS-2的经验教训。

Understanding the applicability of results from primary care trials: lessons learned from applying PRECIS-2.

作者信息

Forbes Gordon, Loudon Kirsty, Treweek Shaun, Taylor Stephanie J C, Eldridge Sandra

机构信息

Centre for Primary Care and Public Health, Queen Mary University of London, Yvonne Carter Building, 58 Turner Street, London E1 2AB, UK.

Nursing, Midwifery and Allied Health Professions Research Unit, University of Stirling, Stirling FK9 4LA, UK.

出版信息

J Clin Epidemiol. 2017 Oct;90:119-126. doi: 10.1016/j.jclinepi.2017.06.007. Epub 2017 Jun 17.

DOI:10.1016/j.jclinepi.2017.06.007
PMID:28629699
Abstract

OBJECTIVE

To compare two approaches for trial teams to apply PRECIS-2 to pragmatic trials: independent scoring and scoring following a group discussion.

STUDY DESIGN AND SETTING

We recruited multidisciplinary teams who were conducting or had conducted trials in primary care in collaboration with the Pragmatic Clinical Trials Unit, Queen Mary University of London. Each team carried out two rounds of scoring on the nine PRECIS-2 domains: first independently using an online version of PRECIS-2 and second following a discussion.

RESULTS

Seven teams took part in the study. Before the discussion, within-team agreement in scores was generally poor and not all raters were able to score all domains; agreement improved after the discussion. The PRECIS-2 wheels suggested that the trials were pragmatic, although some domains were more pragmatic than others.

CONCLUSION

PRECIS-2 can facilitate information exchange within trial teams. To apply PRECIS-2 successfully, we recommend a discussion between those with detailed understanding of what usual care is for the intervention, the trial's design including operational and technical aspects, and the PRECIS-2 domains. For some cluster-randomized trials, greater insight may be gained by plotting two PRECIS-2 wheels, one at the individual participant level and another at the cluster level.

摘要

目的

比较试验团队将PRECIS-2应用于实用性试验的两种方法:独立评分和小组讨论后评分。

研究设计与背景

我们招募了多学科团队,这些团队与伦敦玛丽女王大学实用临床试验单位合作,正在或已经在初级保健领域开展试验。每个团队对PRECIS-2的九个领域进行两轮评分:第一轮独立使用PRECIS-2的在线版本,第二轮在讨论后进行。

结果

七个团队参与了该研究。讨论前,团队内部评分的一致性普遍较差,并非所有评分者都能对所有领域进行评分;讨论后一致性有所提高。PRECIS-2轮显示这些试验具有实用性,尽管有些领域比其他领域更具实用性。

结论

PRECIS-2可促进试验团队内部的信息交流。为了成功应用PRECIS-2,我们建议对干预措施的常规护理、试验设计(包括操作和技术方面)以及PRECIS-2领域有详细了解的人员之间进行讨论。对于一些整群随机试验,通过绘制两个PRECIS-2轮(一个在个体参与者层面,另一个在整群层面)可能会获得更深入的见解。

相似文献

1
Understanding the applicability of results from primary care trials: lessons learned from applying PRECIS-2.理解初级保健试验结果的适用性:应用PRECIS-2的经验教训。
J Clin Epidemiol. 2017 Oct;90:119-126. doi: 10.1016/j.jclinepi.2017.06.007. Epub 2017 Jun 17.
2
Comments, suggestions, and criticisms of the Pragmatic Explanatory Continuum Indicator Summary-2 design tool: a citation analysis.对实用解释连续体指标总结-2设计工具的评论、建议及批评:一项引文分析
J Clin Epidemiol. 2024 Dec;176:111534. doi: 10.1016/j.jclinepi.2024.111534. Epub 2024 Sep 14.
3
The PRECIS-2 tool has good interrater reliability and modest discriminant validity.PRECIS-2工具具有良好的评分者间信度和适度的区分效度。
J Clin Epidemiol. 2017 Aug;88:113-121. doi: 10.1016/j.jclinepi.2017.06.001. Epub 2017 Jun 8.
4
Improving the relevance of randomised trials to primary care: a qualitative study investigating views towards pragmatic trials and the PRECIS-2 tool.提高随机试验与初级保健的相关性:一项关于对实用试验和PRECIS-2工具看法的定性研究
Trials. 2019 Dec 11;20(1):711. doi: 10.1186/s13063-019-3812-7.
5
Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains.构建对话:使用PRECIS-2评分来促进对实用试验设计领域的理解。
Trials. 2017 Nov 10;18(1):532. doi: 10.1186/s13063-017-2267-y.
6
A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems.在两个养老院系统的一项实用、整群随机临床试验中,对PRECIS-2进行动态应用以评估实施情况。
Trials. 2018 Aug 22;19(1):453. doi: 10.1186/s13063-018-2817-y.
7
Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory.国立卫生研究院(NIH)医疗保健系统研究协作实验室中PRECIS评级的使用。
Trials. 2016 Jan 16;17:32. doi: 10.1186/s13063-016-1158-y.
8
Integrating pragmatic and implementation science randomized clinical trial approaches: a PRagmatic Explanatory Continuum Indicator Summary-2 (PRECIS-2) analysis.整合语用学和实施科学随机临床试验方法:实用解释连续体指标综合-2(PRECIS-2)分析。
Trials. 2023 Apr 21;24(1):288. doi: 10.1186/s13063-023-07313-0.
9
The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.PRECIS-2 工具似乎无法区分掩蔽试验和开放标签试验的实用主义程度。
Eur J Clin Pharmacol. 2021 Apr;77(4):539-546. doi: 10.1007/s00228-020-03030-8. Epub 2020 Oct 26.
10
How pragmatic are randomized trials of remdesivir and favipiravir for in-hospital treatment of COVID-19: a descriptive methodological review of trial design using the PRECIS-2 framework.瑞德西韦和法匹拉韦治疗 COVID-19 院内治疗的随机试验有多实用:使用 PRECIS-2 框架对试验设计进行描述性方法学评价。
J Clin Epidemiol. 2022 Dec;152:193-200. doi: 10.1016/j.jclinepi.2022.10.013. Epub 2022 Oct 18.

引用本文的文献

1
How pragmatic are randomised controlled trials evaluating minimally invasive surgery for oesophageal cancer? A methodological review of trial design using the Pragmatic-Explanatory Continuum Indicator Summary-2 (PRECIS-2) tool.评估食管癌微创手术的随机对照试验有多实用?使用实用-解释性连续统指标总结-2(PRECIS-2)工具对试验设计进行的方法学综述。
BMJ Open. 2024 Dec 20;14(12):e078417. doi: 10.1136/bmjopen-2023-078417.
2
Using PRECIS-2 in Chinese herbal medicine randomized controlled trials for irritable bowel syndrome: A methodological exploration based on literature.PRECIS-2在中国草药治疗肠易激综合征随机对照试验中的应用:基于文献的方法学探索
Integr Med Res. 2024 Sep;13(3):101053. doi: 10.1016/j.imr.2024.101053. Epub 2024 May 31.
3
Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments.分析抗肿瘤治疗的语用标记试验的特点和实用主义程度。
BMC Med Res Methodol. 2023 Jun 24;23(1):148. doi: 10.1186/s12874-023-01975-9.
4
Design characteristics of comparative effectiveness trials for the relief of symptomatic dyspepsia: A systematic review.缓解症状性消化不良的比较效果试验的设计特征:一项系统评价。
Integr Med Res. 2021 Jun;10(2):100663. doi: 10.1016/j.imr.2020.100663. Epub 2020 Sep 22.
5
The PRECIS-2 tool seems not to be useful to discriminate the degree of pragmatism of medicine masked trials from that of open-label trials.PRECIS-2 工具似乎无法区分掩蔽试验和开放标签试验的实用主义程度。
Eur J Clin Pharmacol. 2021 Apr;77(4):539-546. doi: 10.1007/s00228-020-03030-8. Epub 2020 Oct 26.
6
How pragmatic are the randomised trials used in recommendations for control of glycosylated haemoglobin levels in type 2 diabetic patients in general practice: an application of the PRECIS II tool.用于一般实践中 2 型糖尿病患者糖化血红蛋白水平控制推荐的随机试验有多么实用:PRECIS II 工具的应用。
Trials. 2020 Mar 19;21(1):281. doi: 10.1186/s13063-020-4215-5.
7
The OaSiS trial: A hybrid type II, national cluster randomized trial to implement smoking cessation during CT screening for lung cancer.OaSiS 试验:一项混合 II 型、全国性的聚类随机试验,旨在在肺癌 CT 筛查期间实施戒烟。
Contemp Clin Trials. 2020 Apr;91:105963. doi: 10.1016/j.cct.2020.105963. Epub 2020 Feb 20.
8
Improving the relevance of randomised trials to primary care: a qualitative study investigating views towards pragmatic trials and the PRECIS-2 tool.提高随机试验与初级保健的相关性:一项关于对实用试验和PRECIS-2工具看法的定性研究
Trials. 2019 Dec 11;20(1):711. doi: 10.1186/s13063-019-3812-7.
9
Pragmatic Trials in Genomic Medicine: The Integrating Pharmacogenetics In Clinical Care (I-PICC) Study.基因组医学中的实用临床试验:整合药物基因组学于临床照护(I-PICC)研究。
Clin Transl Sci. 2020 Mar;13(2):381-390. doi: 10.1111/cts.12723. Epub 2019 Dec 18.
10
Evaluating the effectiveness and cost-effectiveness of the Smoking Treatment Optimisation in Pharmacies (STOP) intervention: protocol for a cluster randomised controlled trial.评估药店戒烟治疗优化(STOP)干预措施的效果和成本效益:一项集群随机对照试验方案。
Trials. 2019 Jun 10;20(1):337. doi: 10.1186/s13063-019-3368-6.